Page last updated: 2024-08-22

trolamine salicylate and Armstrong Syndrome

trolamine salicylate has been researched along with Armstrong Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Auger, JL; Balfour, HH; Bilgic, H; Binstadt, BA; Bottini, N; Campbell, AM; Chan, AC; Cheng, G; Corbett, JA; Curtsinger, JM; Hasegawa, K; Ley, K; Mescher, MF; Mikulski, Z; Peterson, EJ; Sawatzke, K; Schmeling, DO; Shaheen, ZR; Shaked, I; Shoyama, FM; Stanford, SM; Wang, Y; Zhou, W1

Other Studies

1 other study(ies) available for trolamine salicylate and Armstrong Syndrome

ArticleYear
The autoimmunity-associated gene PTPN22 potentiates toll-like receptor-driven, type 1 interferon-dependent immunity.
    Immunity, 2013, Jul-25, Volume: 39, Issue:1

    Topics: Animals; Arthritis; Autoimmunity; Cell Line; Cells, Cultured; Colitis; Dextran Sulfate; HEK293 Cells; Host-Pathogen Interactions; Humans; Immunity; Immunoblotting; Interferon Type I; Lymphocytic Choriomeningitis; Lymphocytic choriomeningitis virus; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Myeloid Cells; Protein Tyrosine Phosphatase, Non-Receptor Type 22; Reverse Transcriptase Polymerase Chain Reaction; TNF Receptor-Associated Factor 3; Toll-Like Receptors; Ubiquitination

2013